![Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF at ASGCT | Hearing Health & Technology Matters Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF at ASGCT | Hearing Health & Technology Matters](https://hearinghealthmatters.org/wp-content/uploads/2022/05/akousprez.jpg)
Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF at ASGCT | Hearing Health & Technology Matters
NEA on Twitter: "🎉 Congratulations, Akouos! 👏🏽🤩🚀 Akouos to be acquired by @LillyPad: https://t.co/3qKl9lN3Wo https://t.co/UPMY69oh82" / Twitter
AKOUOS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,
![Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF | Hearing Health & Technology Matters Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF | Hearing Health & Technology Matters](https://hearinghealthmatters.org/wp-content/uploads/2022/09/akouoslogo.jpg)
Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF | Hearing Health & Technology Matters
![Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders | Technology Networks Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/294747/lonza-akouos-and-mee-announce-strategic-gene-therapy-license-agreements-on-hearing-and-balance-294747-960x540.jpg?cb=9426958)